Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jul-Aug;14(4):395-403.
doi: 10.1016/j.dsx.2020.04.018. Epub 2020 Apr 17.

Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression

Affiliations
Meta-Analysis

Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression

Ian Huang et al. Diabetes Metab Syndr. 2020 Jul-Aug.

Abstract

Background and aims: Diabetes Mellitus (DM) is chronic conditions with devastating multi-systemic complication and may be associated with severe form of Coronavirus Disease 2019 (COVID-19). We conducted a systematic review and meta-analysis in order to investigate the association between DM and poor outcome in patients with COVID-19 pneumonia.

Methods: Systematic literature search was performed from several electronic databases on subjects that assess DM and outcome in COVID-19 pneumonia. The outcome of interest was composite poor outcome, including mortality, severe COVID-19, acute respiratory distress syndrome (ARDS), need for intensive care unit (ICU) care, and disease progression.

Results: There were a total of 6452 patients from 30 studies. Meta-analysis showed that DM was associated with composite poor outcome (RR 2.38 [1.88, 3.03], p < 0.001; I2: 62%) and its subgroup which comprised of mortality (RR 2.12 [1.44, 3.11], p < 0.001; I2: 72%), severe COVID-19 (RR 2.45 [1.79, 3.35], p < 0.001; I2: 45%), ARDS (RR 4.64 [1.86, 11.58], p = 0.001; I2: 9%), and disease progression (RR 3.31 [1.08, 10.14], p = 0.04; I2: 0%). Meta-regression showed that the association with composite poor outcome was influenced by age (p = 0.003) and hypertension (p < 0.001). Subgroup analysis showed that the association was weaker in studies with median age ≥55 years-old (RR 1.92) compared to <55 years-old (RR 3.48), and in prevalence of hypertension ≥25% (RR 1.93) compared to <25% (RR 3.06). Subgroup analysis on median age <55 years-old and prevalence of hypertension <25% showed strong association (RR 3.33) CONCLUSION: DM was associated with mortality, severe COVID-19, ARDS, and disease progression in patients with COVID-19.

Keywords: COVID-19; Coronavirus; Diabetes mellitus; Mortality; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1
Fig. 1
Prisma flowchart.
Fig. 2
Fig. 2
Diabetes Mellitus and Poor Outcome. Forest-plot shows that diabetes mellitus was associated with increased composite poor outcome and its subgroup which comprises of mortality, severe COVID-19, ARDS, need for ICU care, and disease progression in patients with COVID-19. ARDS: Acute Respiratory Distress Syndrome, COVID-19: Coronavirus Disease 2019, ICU: Intensive Care Unit.
Fig. 3
Fig. 3
Bubble-plot for Meta-regression. Meta-regression analysis showed that the association between diabetes mellitus and composite poor outcome was affected by age [A] and hypertension [B], but not by cardiovascular diseases [C].
Fig. 4
Fig. 4
Publication Bias Analysis. The Begg’s funnel-plot analysis showed a qualitatively symmetrical inverted funnel-plot for the association between diabetes mellitus and composite poor outcome [A]. Regression-based Harbord’s test showed indication of small-study effects for hypertension and composite poor outcome.

Comment in

References

    1. World Health Organization . 2020. Coronavirus disease 2019 (COVID-19) situation report – 78.
    1. Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;6736:1–9. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Guo W., Li M., Dong Y., Zhou H., Zhang Z., Tian C. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020 doi: 10.1002/dmrr.3319. - DOI - PMC - PubMed
    1. Ma R.C.W., Holt R.I.G. COVID-19 and diabetes. Diabet Med. 2020 doi: 10.1111/dme.14300. - DOI - PMC - PubMed

MeSH terms